BLPH logo

Bellerophon Therapeutics (BLPH) Depreciation And Amortization

Annual D&A

$65.00 K
-$37.00 K-36.27%

December 31, 2022

Summary

Performance

1-Year Change

-36.27%

3-Year Change

-81.32%

5-Year Change

-82.57%

15-Year Change

-82.57%

BLPH Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$429.00 K
BLPH annual depreciation & amortization is currently -84.85% below its historical high of $429.00 thousand

3-Year Low

$65.00 K
BLPH annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BLPH previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BLPH next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$22.38 M
BLPH annual total expenses is $22.38 million

Annual Operating Expenses

$22.38 M
BLPH annual total operating expenses is $22.38 million

Annual Cost Of Goods Sold

-
BLPH annual cost of goods sold value is unknown

Annual Interest Expense

-
BLPH annual interest expense value is unknown

Quarterly D&A

$0.00
-$1000.00-100.00%

September 30, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

BLPH Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$104.00 K
BLPH quarterly depreciation & amortization is currently -100.00% below its historical high of $104.00 thousand

3-Year Low

$0.00
BLPH quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
BLPH previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
BLPH next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$2.17 M
BLPH quarterly total expenses is $2.17 million

Quarterly Operating Expenses

$2.17 M
BLPH quarterly total operating expenses is $2.17 million

Quarterly Cost Of Goods Sold

-
BLPH quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
BLPH quarterly interest expense value is unknown

TTM D&A

$6000.00
-$21.00 K-77.78%

September 30, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

-92.68%

3-Year Change

-92.68%

5-Year Change

-92.68%

BLPH TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$405.00 K
BLPH TTM depreciation & amortization is currently -98.52% below its historical high of $405.00 thousand

3-Year Low

$6000.00
BLPH TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
BLPH previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
BLPH next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$22.38 M
BLPH annual total expenses is $22.38 million

Annual Operating Expenses

$22.38 M
BLPH annual total operating expenses is $22.38 million

TTM Cost Of Goods Sold

-
BLPH TTM cost of goods sold value is unknown

TTM Interest Expense

-
BLPH TTM interest expense value is unknown

BLPH Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-36.3%-100.0%-92.7%
3 y3 years-81.3%-100.0%-92.7%
5 y5 years-82.6%-100.0%-92.7%

BLPH Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-36.3%at low-100.0%at low-94.1%at low
5 y5-year-81.3%at low-100.0%at low-98.3%at low
alltimeall time-84.8%at low-100.0%at low-98.5%at low

Bellerophon Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2023
-
$0.00(-100.0%)
$6000.00(-77.8%)
Jun 2023
-
$1000.00(0.0%)
$27.00 K(-40.0%)
Mar 2023
-
$1000.00(-75.0%)
$45.00 K(-30.8%)
Dec 2022
$65.00 K(-36.3%)
$4000.00(-81.0%)
$65.00 K(-20.7%)
Sep 2022
-
$21.00 K(+10.5%)
$82.00 K(-3.5%)
Jun 2022
-
$19.00 K(-9.5%)
$85.00 K(-9.6%)
Mar 2022
-
$21.00 K(0.0%)
$94.00 K(-7.8%)
Dec 2021
$102.00 K(-30.6%)
$21.00 K(-12.5%)
$102.00 K(-7.3%)
Sep 2021
-
$24.00 K(-14.3%)
$110.00 K(-5.2%)
Jun 2021
-
$28.00 K(-3.4%)
$116.00 K(-10.8%)
Mar 2021
-
$29.00 K(0.0%)
$130.00 K(-11.6%)
Dec 2020
$147.00 K(-57.8%)
$29.00 K(-3.3%)
$147.00 K(-27.6%)
Sep 2020
-
$30.00 K(-28.6%)
$203.00 K(-21.9%)
Jun 2020
-
$42.00 K(-8.7%)
$260.00 K(-15.0%)
Mar 2020
-
$46.00 K(-45.9%)
$306.00 K(-12.1%)
Dec 2019
$348.00 K(-3.9%)
$85.00 K(-2.3%)
$348.00 K(-1.7%)
Sep 2019
-
$87.00 K(-1.1%)
$354.00 K(-0.8%)
Jun 2019
-
$88.00 K(0.0%)
$357.00 K(-0.6%)
Mar 2019
-
$88.00 K(-3.3%)
$359.00 K(-0.8%)
Dec 2018
$362.00 K
$91.00 K(+1.1%)
$362.00 K(+0.3%)
DateAnnualQuarterlyTTM
Sep 2018
-
$90.00 K(0.0%)
$361.00 K(-0.3%)
Jun 2018
-
$90.00 K(-1.1%)
$362.00 K(-0.8%)
Mar 2018
-
$91.00 K(+1.1%)
$365.00 K(-2.1%)
Dec 2017
$373.00 K(-6.8%)
$90.00 K(-1.1%)
$373.00 K(-2.4%)
Sep 2017
-
$91.00 K(-2.2%)
$382.00 K(-2.1%)
Jun 2017
-
$93.00 K(-6.1%)
$390.00 K(-1.3%)
Mar 2017
-
$99.00 K(0.0%)
$395.00 K(-1.3%)
Dec 2016
$400.00 K(+6.1%)
$99.00 K(0.0%)
$400.00 K(-1.2%)
Sep 2016
-
$99.00 K(+1.0%)
$405.00 K(+2.3%)
Jun 2016
-
$98.00 K(-5.8%)
$396.00 K(+1.8%)
Mar 2016
-
$104.00 K(0.0%)
$389.00 K(+3.2%)
Dec 2015
$377.00 K(-2.8%)
$104.00 K(+15.6%)
$377.00 K(+2.7%)
Sep 2015
-
$90.00 K(-1.1%)
$367.00 K(-1.6%)
Jun 2015
-
$91.00 K(-1.1%)
$373.00 K(-1.3%)
Mar 2015
-
$92.00 K(-2.1%)
$378.00 K(-2.6%)
Dec 2014
$388.00 K(-9.6%)
$94.00 K(-2.1%)
$388.00 K(+32.0%)
Sep 2014
-
$96.00 K(0.0%)
$294.00 K(+48.5%)
Jun 2014
-
$96.00 K(-5.9%)
$198.00 K(+94.1%)
Mar 2014
-
$102.00 K
$102.00 K
Dec 2013
$429.00 K(+404.7%)
-
-
Dec 2012
$85.00 K
-
-

FAQ

  • What is Bellerophon Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics annual D&A year-on-year change?
  • What is Bellerophon Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics quarterly D&A year-on-year change?
  • What is Bellerophon Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics TTM D&A year-on-year change?

What is Bellerophon Therapeutics annual depreciation & amortization?

The current annual D&A of BLPH is $65.00 K

What is the all time high annual D&A for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high annual depreciation & amortization is $429.00 K

What is Bellerophon Therapeutics annual D&A year-on-year change?

Over the past year, BLPH annual depreciation & amortization has changed by -$37.00 K (-36.27%)

What is Bellerophon Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of BLPH is $0.00

What is the all time high quarterly D&A for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high quarterly depreciation & amortization is $104.00 K

What is Bellerophon Therapeutics quarterly D&A year-on-year change?

Over the past year, BLPH quarterly depreciation & amortization has changed by -$21.00 K (-100.00%)

What is Bellerophon Therapeutics TTM depreciation & amortization?

The current TTM D&A of BLPH is $6000.00

What is the all time high TTM D&A for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high TTM depreciation & amortization is $405.00 K

What is Bellerophon Therapeutics TTM D&A year-on-year change?

Over the past year, BLPH TTM depreciation & amortization has changed by -$76.00 K (-92.68%)